Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Altimmune Inc (ALT)

Altimmune Inc (ALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
1 Telemedicine Stock I Wouldn't Touch With a 10-Foot Pole (Hint: It's Not Teladoc)

Telemedicine once seemed like it was going to revolutionize healthcare.

LLY : 915.04 (+1.11%)
PFE : 29.66 (-0.30%)
NVO : 134.88 (+2.14%)
TDOC : 9.18 (+0.99%)
AMZN : 189.87 (+1.85%)
NVDA : 117.87 (+3.97%)
SFIX : 4.18 (+0.97%)
VKTX : 68.16 (+5.76%)
ALT : 7.57 (+1.88%)
RHHBY : 39.4600 (-0.38%)
HIMS : 16.92 (+3.74%)
Prediction: This Weight Loss Stock Will Be Acquired Within the Next Year

Altimmune is a little-known pharmaceutical company looking to disrupt the weight loss space.

NVO : 134.88 (+2.14%)
LLY : 915.04 (+1.11%)
ALT : 7.57 (+1.88%)
2 Small-Cap Stocks Under $20 With Over 220% Upside Potential

Wall Street is forecasting multibagger returns from these two small-cap biotech stocks over the next year.

LLY : 915.04 (+1.11%)
NVO : 134.88 (+2.14%)
MRK : 117.23 (-1.19%)
EYPT : 9.18 (+3.03%)
ALT : 7.57 (+1.88%)
Are Eli Lilly and Novo Nordisk Too Expensive For You? Here Are 4 Other Potential Weight Loss Stocks You May Want to Consider Right Now.

The popularity surrounding weight loss drugs such as Mounjaro and Ozempic has brought Eli Lilly and Novo Nordisk newfound growth.

LLY : 915.04 (+1.11%)
NVO : 134.88 (+2.14%)
VKTX : 68.16 (+5.76%)
ALT : 7.57 (+1.88%)
PFE : 29.66 (-0.30%)
RHHBY : 39.4600 (-0.38%)
Can These 2 Biotechs Beat Eli Lilly and Novo Nordisk in Weight-Loss Drugs?

At least one of the pair has a credible shot at finding a home in the market.

LLY : 915.04 (+1.11%)
ALT : 7.57 (+1.88%)
TERN : 10.04 (-1.67%)
Better GLP-1 Biotech Stock: Altimmune vs. Viking Therapeutics

Both competitors have promising lead programs, and enough cash, too.

LLY : 915.04 (+1.11%)
ALT : 7.57 (+1.88%)
VKTX : 68.16 (+5.76%)
3 Reasons Why Altimmune Stock Could Be the Next Viking Therapeutics

While their share prices have traveled different paths recently, the similarity between the two companies is striking.

LLY : 915.04 (+1.11%)
MS : 100.73 (+1.44%)
ALT : 7.57 (+1.88%)
VKTX : 68.16 (+5.76%)
If These 3 Words Are True, Altimmune's Weight Loss Candidate Could Beat Novo Nordisk's Wegovy

The market for weight loss medicines keeps getting hotter and hotter.

ALT : 7.57 (+1.88%)
NVO : 134.88 (+2.14%)
Altimmune (ALT) Stock Soars 27%: Phase 2 Data on Obesity Drug Ignites Market Optimism

In a remarkable turn of events, Altimmune (NASDAQ: ALT) witnessed a staggering 27% surge in its stock price this morning, fueled by promising clinical data from its Phase 2 trials and heightened investor...

ALT : 7.57 (+1.88%)
Altimmune (ALT) Stock Soars 27%: Phase 2 Data on Obesity Drug Ignites Market Optimism

In a remarkable turn of events, Altimmune (NASDAQ: ALT) witnessed a staggering 27% surge in its stock price this morning, fueled by promising clinical data from its Phase 2 trials and heightened investor...

ALT : 7.57 (+1.88%)

Barchart Exclusives

1 Growth Stock Under $20 to Invest in the Nuclear Energy Boom
This growth stock has doubled this year but is way below its highs made in July. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar